Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€79.80

€79.80

-4.090%
-3.4
-4.090%
€104.79
 
16:38 / Tradegate WKN: 884113 / Symbol: BSX / Name: Boston Scient / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Boston Scientific Stock

Heavy losses for Boston Scientific today as the stock fell by -€3.400 (-4.090%).
With 62 Buy predictions and not a single Sell prediction Boston Scientific is an absolute favorite of our community.
With a target price of 104 € there is a positive potential of 30.33% for Boston Scientific compared to the current price of 79.8 €.
So far the community has only identified positive things for Boston Scientific stock. The most positive votes were given for criterium "Valuation (undervalued/overvalued)".

Pros and Cons of Boston Scientific in the next few years

Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Boston Scientific vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Boston Scientific -4.090% 0.483% -7.965% 10.199% -4.368% 110.367% 155.411%
Veeva Systems A -1.930% 7.542% 10.252% 34.606% 24.902% 50.874% 5.750%
Thermo Fisher Scientific Inc. 5.540% 3.911% -1.935% -25.648% -17.272% -20.236% 9.736%
Waters Corp. 3.680% 0.829% -1.046% -21.027% -28.178% -9.417% 52.934%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financials of Boston Scientific Corporation (BSX) reveals a complex picture of a company operating in the Healthcare Equipment & Supplies sector. With a strong market capitalization eyeing \$101.65 billion, Boston Scientific displays robust revenue metrics alongside significant growth in earnings over the past few years. However, the financial landscape also presents certain challenges, particularly regarding profitability margins and quite high valuation ratios. The comprehensive examination of its balance sheet, cash flow statements, income statements, and financial ratios paints a vivid portrayal of the company’s operational efficiency and market positioning.

Robust Revenue Growth: Boston Scientific has shown impressive revenue growth, with a trailing twelve-month revenue of over \$15.22 billion and a quarterly revenue growth year over year of 14.5%. This growth indicates strong market demand for its products, reflecting a company that can effectively expand and capture more market share.

Strong Profit Margins: The profit margin sits at 12%, which is quite competitive given the industry standards. Additionally, the operating margin of 20.39% demonstrates an efficient cost structure relative to its revenues. This is a sign of effective management that is keeping its operating costs under control while still generating substantial sales.

Comments

Prediction Buy
Perf. (%) -2.39%
Target price 103.068
Change
Ends at 01.10.26

Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $121.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.39%
Target price 112.438
Change
Ends at 01.10.26

Boston Scientific (NYSE:BSX) had its price target raised by analysts at BTIG Research from $127.00 to $132.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.39%
Target price 109.030
Change
Ends at 01.10.26

Boston Scientific (NYSE:BSX) had its price target raised by analysts at Robert W. Baird from $123.00 to $128.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat
Show more